Expression of TNFα receptors on immunocompetent cells is increased in atopic dermatitis. / Lopatnikova, Julia A.; Alshevskaya, Alina A.; Krugleeva, Olga L. et al.
In: International Archives of Allergy and Immunology, Vol. 174, No. 3-4, 12.2017, p. 151-160.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Expression of TNFα receptors on immunocompetent cells is increased in atopic dermatitis
AU - Lopatnikova, Julia A.
AU - Alshevskaya, Alina A.
AU - Krugleeva, Olga L.
AU - Nepomnyschih, Vera M.
AU - Gladkikh, Victor S.
AU - Lukinov, Vitaliy L.
AU - Karaulov, Alexander V.
AU - Sennikov, Sergey Vitalievich
N1 - Publisher Copyright: © 2017 S. Karger AG, Basel.
PY - 2017/12
Y1 - 2017/12
N2 - Background: Expression levels of cytokine and growth factor receptors have been found to be important in the regulation of their action. Tumor necrosis factor-α (TNFα) is actively involved in inflammation processes in atopic dermatitis (AD), but the role of TNFα membrane receptors (TNFR) and their regulatory function in AD remains unclear. Aim: We aimed to determine the associations of parameters of TNFRα expression on immunocompetent cells with disease severity before and after therapy in AD patients. Methods: TNFRα expression on T cells, B cells, and monocytes was evaluated by flow cytometry. To determine receptor numbers on the cells, Quantibrite PE beads were used. The content of soluble mediators was evaluated by ELISA. To reveal linear relationships between the index scoring AD (SCORAD) and the studied parameters, multiple linear regression model building was used. Results: TNFR1 and TNFR2 expression in lymphocyte and monocyte populations of AD patients was higher than in healthy individuals (HI). At the same time an increased percentage of positive cells was not associated with high receptor density, and vice versa. Serum content of TNFα, both soluble receptors, the number of TNFR2/T cells, and the percentage of TNFR2+ monocytes were found to be strongly associated with the SCORAD index. Conclusion: AD patients had increased TNFR expression on immune cells. Changes in the parameters of TNFRα expression compared to HI were associated with the disease severity index SCORAD.
AB - Background: Expression levels of cytokine and growth factor receptors have been found to be important in the regulation of their action. Tumor necrosis factor-α (TNFα) is actively involved in inflammation processes in atopic dermatitis (AD), but the role of TNFα membrane receptors (TNFR) and their regulatory function in AD remains unclear. Aim: We aimed to determine the associations of parameters of TNFRα expression on immunocompetent cells with disease severity before and after therapy in AD patients. Methods: TNFRα expression on T cells, B cells, and monocytes was evaluated by flow cytometry. To determine receptor numbers on the cells, Quantibrite PE beads were used. The content of soluble mediators was evaluated by ELISA. To reveal linear relationships between the index scoring AD (SCORAD) and the studied parameters, multiple linear regression model building was used. Results: TNFR1 and TNFR2 expression in lymphocyte and monocyte populations of AD patients was higher than in healthy individuals (HI). At the same time an increased percentage of positive cells was not associated with high receptor density, and vice versa. Serum content of TNFα, both soluble receptors, the number of TNFR2/T cells, and the percentage of TNFR2+ monocytes were found to be strongly associated with the SCORAD index. Conclusion: AD patients had increased TNFR expression on immune cells. Changes in the parameters of TNFRα expression compared to HI were associated with the disease severity index SCORAD.
KW - Membrane-bound receptors
KW - Tumor necrosis factor
KW - Receptor expression density
KW - Atopic dermatitis
KW - NECROSIS-FACTOR TNF
KW - MONONUCLEAR-CELLS
KW - SPLICED VARIANT
KW - T-CELL
KW - MONOCYTES
KW - SKIN
KW - KERATINOCYTES
KW - ACTIVATION
KW - LEUKOCYTES
KW - INDUCTION
UR - http://www.scopus.com/inward/record.url?scp=85033452143&partnerID=8YFLogxK
U2 - 10.1159/000481135
DO - 10.1159/000481135
M3 - Article
VL - 174
SP - 151
EP - 160
JO - International Archives of Allergy and Immunology
JF - International Archives of Allergy and Immunology
SN - 1018-2438
IS - 3-4
ER -
ID: 24441542